Clinicopathological features | HER-2 overexpression/amplification | ||
---|---|---|---|
HER-2/neupositive (n = 27) | HER-2/neunegative (n = 200) | P | |
Age | 0.151 | ||
<65 years | 18 | 96 | |
≥65 years | 9 | 104 | |
Sex | 0.765 | ||
male | 18 | 139 | |
female | 9 | 61 | |
Lauren | 0.001 | ||
intestinal | 26 | 118 | |
diffuse | 0 | 49 | |
mixed | 1 | 33 | |
WHO classification | 0.001 | ||
W/D | 9 | 24 | |
M/D | 16 | 97 | |
P/D | 2 | 79 | |
Tumor size | 0.002 | ||
≥5 cm | 18 | 72 | |
<5 cm | 9 | 128 | |
Tumor location | 0.258 | ||
cardia | 21 | 128 | |
corpus | 5 | 45 | |
antrum | 1 | 27 | |
Invasion depth | 0.322 | ||
T1 | 1 | 19 | |
T2 | 4 | 32 | |
T3 | 22 | 149 | |
Lymph node | 0.022 | ||
present | 20 | 118 | |
absent | 7 | 82 | |
TNM stage | 0.320 | ||
I | 3 | 43 | |
II | 6 | 52 | |
III | 18 | 105 | |
Vessel invasion | 0.241 | ||
present | 4 | 16 | |
absent | 23 | 184 | |
Borrmann | 0.133 | ||
I | 4 | 26 | |
II | 17 | 102 | |
III | 6 | 64 | |
IV | 0 | 8 |